Monoamine Oxidase B human, ~2.5 mg per vial, recombinant, expressed in baculovirus infected BTI inse

Application

Monoamine Oxidase B has been used in a study to assess the effect of age in 23 different regions of the human brain. It has also been used in a study to determine the specific locations of monoamine oxidase in the human brain.

Drugs that inhibit monoamine oxidase B activity are used for the treatment of various neurological disorders including depression.

Biochem/physiol Actions

MAO′s are proteins of the mitochondrial membrane. These enzymes are responsible for catalyzing oxidative deamination of endo- and xenobiotic amines. Substrate specificity differs for each isozyme.

General description

Monoamine Oxidase B is a mitochondrial outermembrane flavoenzyme that is a target for antidepressant and neuroprotective drugs.

Unit Definition

kynuramine deamination activity: One unit will deaminate 1 nanomole of kynuramine per minute at pH 7.4 at 37 deg C.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level Manufacturer Storage Temp. Form Price Quantity
3579888 Monoamine Oxidase B human, ~2.5 mg per vial, recombinant, expressed in baculovirus infected BTI inse 100 SIGMA-ALDRICH −70°C liquid
£683.89 (exc VAT) per EACH
-
+
3579889 Monoamine Oxidase B human, ~2.5 mg per vial, recombinant, expressed in baculovirus infected BTI inse 100 SIGMA-ALDRICH −70°C liquid
Click Add to Quote for price and delivery
-
+